NCT06828796View on ClinicalTrials.gov

Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2028

Conditions
Hematologic Disease and DisordersHematopoietic Cell Transplant
Interventions
DRUG

Tacrolimus

Begins Day -1 and continues to Day +90 or Day +180 after transplant

DRUG

Cyclophosphamide

Given Days +3 and +4 after transplant

DRUG

Mycofenolate mofetil

Given Day 0 to Day +35 after transplant

Trial Locations (1)

30342

Northside Hospital, Atlanta

All Listed Sponsors
lead

Northside Hospital, Inc.

OTHER